'Metabolically Active Disease': — What Your PET-CT Report Is Saying
You found this phrase in a report and are reading it before your next appointment. It is a PET-CT term describing how hard cells in a particular area are working — not a verdict, and not the last word. Your oncologist interprets it in the full context of your case.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- A PET-CT finding, not a diagnosis — The phrase describes what the scan measured. A diagnosis requires your full history and, often, tissue from a biopsy.
- Measures activity, not just size — CT shows the shape of an area. PET-CT shows how much glucose the cells there are using. They answer different questions.
- It can appear in different situations — You may see it at initial staging, during treatment, or in a follow-up scan. The meaning differs in each context.
- Your oncologist reads the full report — The phrase is one part of a longer document, and your oncologist interprets the whole picture together.
on Panel
Survival Rate*
Treated
(800+ reviews)
'Metabolically active disease' is a PET-CT term meaning an area of your body is taking up glucose faster than the surrounding tissue. Cancer cells typically do this. The phrase describes what the scan observed — not your prognosis or your treatment plan. Your oncologist interprets this finding alongside your history, biopsy results, and other investigations.
What does 'metabolically active disease' mean?
PET stands for positron emission tomography. Before the scan, you are given a glucose tracer. Areas of your body that use a lot of glucose absorb more of the tracer and show as brighter spots on the image.
When a radiologist writes 'metabolically active disease', they are describing an area where cells are using glucose at a higher-than-normal rate. Cancer cells tend to do this. So does inflamed tissue, and so do some normal organs.
The radiologist describes what the scan shows. They do not have your full history in front of them. Your oncologist reads the report alongside everything else before deciding what the finding means for you.
Terms you will see in the same report
- PET-CT
- A scan that combines a positron emission tomography image — which measures glucose uptake — with a CT image, which shows anatomy. The two together let the radiologist say where a finding is and how metabolically active it is at the same time.
- FDG (fluorodeoxyglucose)
- The radioactive glucose tracer injected before the scan. Cells that use a lot of glucose take up more FDG and appear brighter on the image. Cancer cells often do this, but so can inflammation, infection, and some normal tissues such as the brain and heart.
- SUV (Standardised Uptake Value)
- A number the scanner calculates to express how much tracer a specific area absorbed. A higher number means more activity. Your oncologist uses it to compare areas within the same scan and to track whether activity changes between scans over time.
- FDG-avid
- Another phrase for the same observation. 'FDG-avid disease' and 'metabolically active disease' mean the same thing — the area is absorbing the glucose tracer at a higher rate. You may see either phrase, or both, in the same report.
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Is metabolically active disease worse than finding a mass on CT?
CT and PET-CT answer different questions. A CT scan shows the shape and size of structures in your body. A PET-CT shows how much glucose those structures are using. Comparing the two as better or worse is like comparing the size of a fire with how hot it is burning — they are separate measurements.
An area can look like a significant mass on CT but show no metabolic activity at all. This is often scar tissue or treated disease that has gone quiet. An area can also be metabolically active but too small for CT to measure precisely.
Neither finding is automatically more or less serious than the other. Your oncologist reads both scans together. A concerning finding on one often needs the other to understand what it represents.
Questions families often ask after getting this result
Does it definitely mean cancer is there?
Not always. PET-CT alone cannot confirm a cancer diagnosis — that requires tissue, usually from a biopsy. Some non-cancerous conditions cause increased glucose uptake too, including active inflammation, infection, and certain benign tumours. The radiologist notes the finding; your oncologist and the full clinical picture determine what it represents. If there is genuine uncertainty, a biopsy or a follow-up scan is typically the next step your team will discuss.
Does metabolically active disease mean it has spread?
Not necessarily. Metabolic activity can be found in a primary tumour, in lymph nodes, or at distant sites — and the significance is different in each case. The location matters as much as the finding itself. Your oncologist will explain which areas were active, whether those locations are relevant to your staging, and what, if anything, it changes about your treatment plan.
What does 'no residual metabolic activity' mean?
This phrase appears in follow-up scans after treatment has been given. It means the areas that previously showed up bright on the PET-CT are now metabolically quiet — no significant glucose uptake is visible there any more. For many cancers, ASCO and ESMO guidance treats this as a positive marker of treatment response, though what it means for your ongoing care depends on your specific diagnosis and which treatment you received.
What happens next after this result?
Your oncologist reviews the full report alongside your history and any other investigations before deciding the next step. That might mean a biopsy to confirm what the activity represents, a staging discussion, a change to your treatment, or a comparison with your previous scan to assess response. The PET-CT report is an input into that conversation — it does not make the decision on its own, and neither can this page.
Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Frequently asked questions
What does 'metabolically active disease' mean in plain English?
It means an area of your body is using glucose faster than the surrounding tissue. PET-CT scans detect glucose uptake, and cancer cells tend to use more glucose than normal cells. The phrase describes a finding on the scan — not a diagnosis and not a treatment decision. Your oncologist interprets what it means for your specific situation alongside your history and other results.
Is metabolically active disease serious?
The phrase describes an observation, not a prognosis. What it means depends on where the activity is, how much there is, your cancer type, and whether this is a first scan or a follow-up. Your oncologist cannot answer this from the phrase alone — and neither can a search result. The question to ask at your appointment is what this specific finding means in the context of your case.
Is it different from finding a tumour or a mass?
Yes. A mass on a CT report describes the visible size and shape of an area. 'Metabolically active disease' on a PET-CT describes how much glucose that area is using — a different measurement. The two findings often appear together. Sometimes one appears without the other. CT and PET-CT images are read alongside each other to build a complete picture.
What does the SUV number in my report mean?
SUV stands for Standardised Uptake Value — a number expressing how much of the glucose tracer a specific area absorbed. A higher number means more uptake. Your oncologist uses it to compare areas within the same scan and to track changes between scans. The number only has meaning in the context of your cancer type and your previous results — a single figure does not tell you on its own whether the finding is significant.
Does metabolically active disease mean my treatment is not working?
Not necessarily. The answer depends on whether this is a new finding or a response assessment, what your baseline scan showed, and how much activity remains compared with before treatment. For many cancers, a reduction in metabolic activity is a marker of treatment response, even when some activity is still visible. Your oncologist will compare this scan with your previous one and explain what any change means for your plan.
What should I ask my doctor when I go in?
Ask where the metabolic activity was found and whether it was present on your previous scan. Ask what the finding changes about your treatment. Ask whether a biopsy is needed to confirm what the activity represents. If any phrase in the report is unclear, ask for a plain-language explanation — that is a reasonable thing to expect at your appointment. Writing your questions down beforehand helps you cover them all in the time you have.